moxifloxacin has been researched along with n-acetylneuraminic acid in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (n-acetylneuraminic acid) | Trials (n-acetylneuraminic acid) | Recent Studies (post-2010) (n-acetylneuraminic acid) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 6,736 | 65 | 2,248 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muccioli, GG; Tulkens, PM; Van Bambeke, F; Vandevelde, NM | 1 |
1 other study(ies) available for moxifloxacin and n-acetylneuraminic acid
| Article | Year |
|---|---|
Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms.
Topics: Aged; Aged, 80 and over; Albuterol; Anti-Bacterial Agents; Biofilms; Bronchodilator Agents; Chromatography, High Pressure Liquid; Drug Interactions; Female; Fluoroquinolones; Humans; Ipratropium; Macrolides; Male; Mass Spectrometry; Microbial Viability; Middle Aged; Models, Theoretical; Moxifloxacin; N-Acetylneuraminic Acid; Pneumococcal Infections; Streptococcus pneumoniae; Triazoles | 2015 |